Career Scientific Research Grants Program
The Association for the Advancement of Blood and Biotherapies (AABB) Foundation is offering Early-Career Scientific Research Grants to support original, investigator-initiated research in blood banking, transfusion medicine, and biotherapies.
1 December 2025 (annual cycle: July 1 – Dec 1)
Up to $100,000
Funds awarded in July 2026 after June announcements
Applications are invited across multiple disciplines relevant to transfusion medicine and biotherapies:
Immunology
Alloimmunization, immune modulation, tolerance
Graft-vs-host disease (animal models)
Biology of autoimmune hemolytic anemia
Hematology
Autologous & allogeneic stem cell transplants
Detection of residual disease post-transplant
Growth factors (in vitro/in vivo)
Coagulation factor biochemistry
Immunohematology
Blood group serology
Biochemistry of red cell antigens
Molecular genetics of blood groups
Infectious Diseases
Lyme disease, West Nile Virus, SARS, babesiosis, emerging diseases
Effect of transfusion in HIV+ or immunocompromised patients
Improved detection of transfusion-transmitted diseases
Biotherapies
Cell separation, culture, expansion
Novel cell therapies & viability assays
Pilot studies in regenerative medicine
Stem cell transplantation & cytokine/growth factor studies
Patient Blood Management
Treatment of pre-admission anemia and bleeding
Intra-/postoperative blood recovery
Surgical hemostasis
Appropriate transfusion indications
Physician behavior change
Blood utilization review
Early-career investigators (within 10 years of terminal research degree or medical residency)
Professionals such as MDs, PhDs, medical technologists, transfusion medicine or biotherapies specialists
Must not have received a substantial research grant (e.g., NIH R01)
Must not have previously received an AABB early-career grant (resubmission allowed if criteria still met)
Submission period: July 1 – Dec 1, 2025
Review: By the AABB Foundation Scientific Research Grants Review Committee + external experts
Feedback: Confidential critique sheet provided
Decisions: Announced June 2026
Funding: Disbursed July 2026
Recommendation: This program is highly suitable for postdocs, junior faculty, and early-stage researchers aiming to establish independence in transfusion medicine and biotherapies research.
Next step: Begin drafting a proposal emphasizing novelty, impact on transfusion/biotherapies, feasibility, and potential to generate significant preliminary data for larger future grants.
for more information-